Factors associated with regular cervical cancer screening

International Journal of Gynecology and Obstetrics

Volumn 102, Issue 1, 2008, Pages 28-33

  Grangé, Gilles ^a   Malvy, Denis ^b   Lançon, Florian ^c   Gaudin, Anne Francoise ^c   El Hasnaoui, Abdelkader ^c  

^a Hôpital Cochin Maternité Port Royal ^*  (France)

^b HÔPITAL SAINT ANDRÉ   (France)

^c GLAXOSMITHKLINE   (France)

Author keywords

Cervical cancer; Cervical screening; Human papillomavirus infection; Information; Prevention; Women's education

Indexed keywords

ADULT; AGED; ARTICLE; ATTITUDE TO HEALTH; CANCER SCREENING; EDUCATIONAL STATUS; FEMALE; FRANCE; HEALTH SURVEY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MULTIVARIATE LOGISTIC REGRESSION ANALYSIS; OBSERVATIONAL STUDY; PRIORITY JOURNAL; SEXUAL BEHAVIOR; STATISTICAL MODEL; STEP WISE MULTIPLE REGRESSION; UNIVARIATE ANALYSIS; UTERINE CERVIX CANCER; UTERINE CERVIX CYTOLOGY; VIRUS INFECTION; WART VIRUS;

EID: 46549089773     PISSN: 00207292     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijgo.2008.01.027     Document Type: Article

References (27)

1. Duarte-Franco E., and Franco E.L. Cancer of the uterine cervix. BMC Womens Health 4 suppl 1 (2004) S13
2. Agence nationale d'accréditation et d'évaluation en santé. Assessment of human papilloma virus (HPV) testing in primary screening for cervical cancer in France (May 2004). Gynecol Obstet Fertil 33 5 (2005) 357-360
3. Remontet L., Esteve J., Bouvier A.M., Grosclaude P., Launoy G., Menegoz F., et al. Cancer incidence and mortality in France over the period 1978-2000. Rev Epidemiol Santé Publique 51 1 Pt 1 (2003) 3-30
4. Rocha-Zavaleta L., Yescas G., Cruz R.M., and Cruz-Talonia F. Human papillomavirus infection and cervical ectopy. Int J Gynecol Obstet 85 3 (2004) 259-266
5. Tachezy R., Salakova M., Hamsikova E., Kanka J., Havrankova A., and Vonka V. Prospective study on cervical neoplasia: presence of HPV DNA in cytological smears precedes the development of cervical neoplastic lesions. Sex Transm Infect 79 3 (2003) 191-196
6. Bosch F.X., Lorincz A., Munoz N., Meijer C.J., and Shah K.V. The causal relation between human papillomavirus and cervical cancer. J Clin Pathol 55 (2002) 244-265
7. Walboomers J.M., Jacobs M., Manos M.M., Bosch F.X., Kummer J.A., Shah K.V., et al. Human papillomavirus is a necessary cause of invasive cervical cancer worldwide. J Pathol 189 1 (1999) 12-19
8. Munoz N., Bosch F.X., de Sanjosé S., Herrero R., Castellsaque X., Shah K.V., et al. Epidemiologic classification of human papillomavirus types associated with cervical cancer. N Engl J Med 348 (2003) 518-527
9. Baseman J.G., and Koutsky L.A. The epidemiology of human papillomavirus infections. J Clin Virol 32 suppl (2005) 16-24
10. Clavel C., Masure M., Bory J.P., Puteaux I., Mangeonjean C., Lorenzato M., et al. Human papillomavirus testing in primary screening for the detection of high-grade cervical lesions: a study of 7932 women. Br J Cancer 84 (2001) 1616-1623
11. Bray F., Carstensen B., Moller H., Zappa M., Zakelj M.P., Lawrence G., et al. Incidence trends of adenocarcinoma of the cervix in 13 European countries. Cancer Epidemiol Biomark Prev 14 9 (2005) 2191-2199
12. Eilstein D., Hedelin G., and Schaffer P. Cervical cancer in Bas-Rhin: trend and prediction of the incidence in 2014. J Gynecol Obstet Biol Reprod (Paris) 31 1 (2002) 28-33
13. Boulanger J.C., and Naepels P. Screening and diagnosis of cervical cancer. Rev Prat 51 13 (2001) 1426-1431
14. Lawson H.W., Henson R., Bobo J.K., and Kaeser M.K. Implementing recommendations for the early detection of breast and cervical cancer among low-income women. MMWR Recomm Rep 49 RR-2 (2000) 37-55
15. Ng E., Wilkins R., Fung M.F., and Berthelot J.M. Cervical cancer mortality by neighbourhood income in urban Canada from 1971 to 1996. CMAJ 170 10 (2004) 1545-1549
16. Yabroff K.R., Lawrence W.F., King J.C., Mangan P., Washington K.S., Yi B., et al. Geographic disparities in cervical cancer mortality: what are the roles of risk factor prevalence, screening, and use of recommended treatment?. J Rural Health 21 2 (2005) 149-157
17. Schoenberg N.E., Hopenhayn C., Christian A., Knight E.A., and Rubio A. An in-depth and updated perspective on determinants of cervical cancer screening among central Appalachian women. Women Health 42 2 (2005) 89-105
18. Dietrich A.J., Tobin J.N., Cassells A., Robinson C.M., Greene M.A., Sox C.H., et al. Telephone care management to improve cancer screening among low-income women: a randomized, controlled trial. Ann Intern Med 144 8 (2006) 563-571
19. Coory M., Baade P., and Muller J. Cancer incidence, mortality and survival by rurality and socio-economic status in Queensland (2001), Health Information Centre, Queensland Health, Brisbane, Queensland, Australia
20. Valdespino V.M., and Valdespino V.E. Cervical cancer screening: state of the art. Curr Opin Obstet Gynecol 18 1 (2006) 35-40
21. Cuzick J., Sasieni P., Davies P., Adams J., Normand C., Frater A., et al. A systematic review of the role of human papillomavirus testing within a cervical screening programme. Health Technol Assess 3 14 (1999) 1-196
22. Mubiayi N., Bogaert E., Boman F., Leblanc E., Vinatier D., Leroy J.L., et al. Histoire du suivi cytologique de 148 femmes atteintes d'un cancer invasive du col utérin. Gynecol Obstet Fertil 30 (2002) 210-217
23. Saslow D., Runowicz C.D., Solomon D., Moscicki A.B., Smith R.A., Eyre H.J., et al. American Cancer Society guideline for the early detection of cervical neoplasia and cancer. CA Cancer J Clin 52 6 (2002) 342-362
24. Clifford G.M., Smith J.S., Plummer M., Munoz N., and Francesschi S. Human papillomavirus types in invasive cervical cancer worldwide: a meta-analysis. Br J Cancer 88 (2003) 63-73
25. Deroo M., and Dussaix A.M. Pratique et analyse des enquêtes par sondage (1980), Presses Universitaires de France, Paris, France
26. Institut National de la Statistique et des Études Économiques. Recensement (1999). http://www.insee.fr http://www.insee.fr. Accessed October 23, 2007
27. Tiro J.A., Meissner H.I., Kobrin S., and Chollette V. What do women in the U.S. know about human papillomavirus and cervical cancer?. Cancer Epidemiol Biomark Prev 16 2 (2007) 288-294